![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 43, 41287-41293, October 25, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Although the cytoplasmic domain of the
human Fc
The CY Domain of the Fc
RIa
-Chain (CD64) Alters
-Chain
Tyrosine-based Signaling and Phagocytosis*
§¶,
§,
,
,
,
Departments of Medicine and Microbiology,
The University of Alabama at Birmingham, Birmingham, Alabama 35294,
Department of Medicine, Hospital for Special Surgery and Weill
Medical College of Cornell University, New York, New York 10021, and ** Department of Medicine, University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania 19104
RIa
-chain lacks tyrosine-based
phosphorylation motifs, it modulates receptor cycling and
receptor-specific cytokine production. The cytoplasmic domain of
Fc
RIa is constitutively phosphorylated, and the inhibition of
dephosphorylation with okadaic acid, an inhibitor of type 1 and type 2A
protein serine/threonine phosphatase, inhibits both receptor-induced
activation of the early tyrosine phosphorylation cascade and
receptor-specific phagocytosis. To explore the basis for these effects
of the cytoplasmic domain of Fc
RIa, we developed a series of human
Fc
RIa molecular variants, expressed in the murine macrophage
cell line P388D1, and demonstrate that serine phosphorylation of the
cytoplasmic domain is an important regulatory mechanism. Truncation of
the cytoplasmic domain and mutation of the cytoplasmic domain serine
residues to alanine abolish the okadaic acid inhibition of phagocytic
function. In contrast, the serine mutants did not recapitulate the
selective effects of cytoplasmic domain truncation on cytokine
production. These results demonstrate for the first time a
direct functional role for serine phosphorylation in the
-chain of
Fc
RIa and suggest that the cytoplasmic domain of Fc
RI regulates
the different functional capacities of the Fc
RIa-receptor complex.
*
This work was supported by Grants RO1-AR33062, RO1-AR42476,
and AI-22193 from the National Institutes of Health (NIH). Flow cytometry was supported in part by NIH Core Grant P60-AR20614 (to the
University of Alabama at Birmingham).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion J. Immunol., July 15, 2008; 181(2): 1012 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Qin, J. C. Edberg, A. W. Gibson, G. P. Page, L. Teng, and R. P. Kimberly Differential Gene Expression Modulated by the Cytoplasmic Domain of Fc{gamma}RIa (CD64) {alpha}-Chain J. Immunol., November 15, 2004; 173(10): 6211 - 6219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beekman, J. E. Bakema, J. van der Linden, B. Tops, M. Hinten, M. van Vugt, J. G. J. van de Winkel, and J. H. W. Leusen Modulation of Fc{gamma}RI (CD64) Ligand Binding by Blocking Peptides of Periplakin J. Biol. Chem., August 6, 2004; 279(32): 33875 - 33881. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beekman, J. E. Bakema, J. G. J. van de Winkel, and J. H. W. Leusen Direct interaction between Fc{gamma}RI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity PNAS, July 13, 2004; 101(28): 10392 - 10397. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |